Health Service Focus

28.07.17

A welcome signal on the future of medicines

Source: NHE Jul/Aug 2017

Just before NHE went to press, Jeremy Hunt and Greg Clark issued a letter entitled ‘the UK wants to continue to work with the EU on medicines’. David Stevenson reports on this and recent discussions around Brexit.

An “important and welcome signal”. These are the words of Niall Dickson, CEO of NHS Confederation and co-chair of the Brexit Health Alliance, after the secretaries of health and industry sent a letter to the Financial Times stating that they want to “provide assurance” over the government’s plans for the regulation of medicines as we leave the EU. 

The letter stated that the UK was “fully committed” to continuing to work closely with its European partners in this area: “We have three principles which will help us rise to the challenge of developing a new regulatory system post-Brexit: patients should not be disadvantaged; innovators should be able to get their products into the UK market as quickly and simply as possible; and we continue to play a leading role promoting public health.”

The letter concluded by stating that, whatever the outcomes of the Brexit negotiations, a regulatory system that protects the best interests of patients and supports the UK life science industry to go from strength to strength will be pursued. But it added: “Our door will always be open to a deep and special relationship with the EU which remains the best way to promote improved patient outcomes both in Europe and globally.” 

Responding to the news, Dickson argued that if we get these negotiations wrong, “there is a real danger that patients could be denied access to cutting-edge treatments, and indeed access to a wide range of innovative health technologies”.

The determination of the UK government to continue with a regulatory system that protects and supports the life science sector is very welcome, he added. 

At Confed17, Dickson launched the Brexit Health Alliance, which brings together the NHS, medical research, industry, patients and public health organisations. Its aim is to make sure that issues such as healthcare research, access to technologies and treatment of patients are given the prominence and attention they deserve in the Brexit negotiations. 

“The current EU medicines research, development and regulatory arrangements work well and benefit from the input of UK academics, regulators and industry,” stated Dickson. “For patients in the UK and across Europe we must maintain the highest possible level of collaboration and regulatory alignment.”  

During a recent discussion at Confed17, Sir Hugh Taylor, former permanent secretary at the Department of Health, the current chair of Guy’s and St Thomas’ NHS FT and co-chair of the Brexit Health Alliance, said that the single biggest risk factor for his trust over the next 12 months is workforce issues. On top of this, approximately 15% of the staff at his trust are EU nationals. 

“I think that risk is, in part, a funding issue,” he said. “But also, in part, it is a related set of issues to do with pay, the cost of housing and transport. But the Brexit impact is a compounding factor on workforce issues.

“We have touched on access for UK citizens, and we need to ensure we have reciprocal arrangements in place. Then there is the issue of access to technologies and the supply chain as we are big importers for medicines and tech. 

“There is quite a lot for the NHS and the Department of Health to get their heads around on supply chain issues. It is important that health is supported by a strong research and innovation base.  Universities and medical schools are dependent on international talent. We need to ensure the research and innovation base is improved as a result of EU negotiations. There are lots of areas to explore and lots of conversations to be had.” 

In support of the line from the health and industry secretaries, Professor Alan Boyd, president of the Faculty of Pharmaceutical Medicine, stated that it is essential that the issues of regulation of medicines and devices are properly resolved for the safety and benefit of patients. 

“We would urge the government to closely involve professional bodies representing clinicians and the industry itself as discussions progress, and seek their input and expert advice to enable the best outcome to be achieved for patients and the industry in the UK,” he concluded.

TELL US WHAT YOU THINK

opinion@nationalhealthexecutive.com

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

Social prescribing ‘must not be seen as alternative to GP investment’

22/02/2018Social prescribing ‘must not be seen as alternative to GP investment’

Social prescribing schemes must not be seen as an alternative to investing in GP services, the Royal College of GPs (RCGP) has argued. Chair of ... more >
‘Landmark report’ to seek more compassionate response to patient concerns

22/02/2018‘Landmark report’ to seek more compassionate response to patient concerns

The government has ordered a review into how UK authorities respond to concerns about medical treatments. Speaking in the House of Commons yeste... more >
Existing schemes prove strong ties between NHS and councils ‘would change everything’

22/02/2018Existing schemes prove strong ties between NHS and councils ‘would change everything’

The chance to build a strong partnership between the NHS and local government to the benefit of communities is “the greatest opportunity in... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital e... read more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >
681 149x260 NHE Subscribe button

the scalpel's daily blog

Trusts recognise the value of the GIRFT programme – but it must remain ‘quality first’

09/02/2018Trusts recognise the value of the GIRFT programme – but it must remain ‘quality first’

Cassandra Cameron, policy advisor at NHS Providers, says trusts must be given constructive support – without fear of failure – in order for the Getting It Right First Time (GIRFT) programme to succeed. The NHS GIRFT programme aims for better value in acute hospital and mental health care by using trusts’ clinical, operational and financial data for benchmarking and scrutiny of local performance. Along with efficiency, ... more >
read more blog posts from 'the scalpel' >

comment

Celebrating 75 years of healthcare

14/02/2018Celebrating 75 years of healthcare

Julian Amey, chief executive of the Institute of Healthcare Engineering & Estate Management (IHEEM), outlines what the coming year holds for ... more >
The HSIB approach to maternity investigations

14/02/2018The HSIB approach to maternity investigations

Jane Rintoul, director of strategy and policy and programme director for maternity investigations at the Healthcare Safety Investigation Branch (... more >
Data saves lives

14/02/2018Data saves lives

Kuldeep Sohal, programme manager at Connected Yorkshire, part of Connected Health Cities, discusses how data sharing across the north is improvin... more >
Our work can help ease A&E pressures

09/02/2018Our work can help ease A&E pressures

Last year, NICE guidelines recommended that the NHS should provide more advanced paramedic practitioners (APPs) to relieve pressure on emergency ... more >
Beyond scented candles and quick fixes

07/02/2018Beyond scented candles and quick fixes

Joni Jabbal, researcher at The King’s Fund, asks why quality improvements and innovations are failing to be adopted by the NHS. There ... more >

interviews

Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >
Tackling infection prevention locally

04/10/2017Tackling infection prevention locally

Dr Emma Burnett, a lecturer and researcher in infection prevention at the University of Dundee’s School of Nursing and Midwifery and a boar... more >
Scan4Safety: benefits across the whole supply chain

02/10/2017Scan4Safety: benefits across the whole supply chain

NHE interviews Gillian Fox, head of eProcurement (Scan4Safety) programme at NHS Supply Chain. How has the Scan4Safety initiative evolved sin... more >
Simon Stevens: A hunger for innovation

25/09/2017Simon Stevens: A hunger for innovation

Simon Stevens, chief executive of NHS England, knows that the health service is already a world leader when it comes to medical advances – ... more >